1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Outset Medical, Inc.

Outset Medical, Inc.

OM
Outset Medical, Inc.US flagNASDAQ Global Select
4.13
USD
+0.01
- -
76.56MMarket Cap

Total Valuation

Outset Medical, Inc. carries a market capitalization of 76.56M, placing it among publicly traded companies globally. Its enterprise value stands at 13.76M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap76.56M
Enterprise Value13.76M

Share Statistics

Outset Medical, Inc. currently has 18.53M shares outstanding.

Shares Outstanding18.53M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.59, and the price-to-book ratio stands at -0.06.

PE RatioN/A
PS Ratio0.59
PB Ratio-0.06
P/TBV Ratio0.62
P/FCF Ratio-2.10
P/OCF Ratio-2.05

Enterprise Valuation

EV / Sales0.12
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Outset Medical, Inc. maintains a current ratio of 6.29, meaning it holds 6.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 90.98, indicating elevated leverage, while an interest coverage ratio of -4.61 demonstrates limited ability to service its debt obligations.

Current Ratio6.29
Quick Ratio4.84
Debt / Equity90.98
Debt / EBITDA-1.60
Interest Coverage-4.61

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-27.18
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.32

Taxes

Income Tax820,000.00
Effective Tax RateN/A

Stock Price Statistics

Outset Medical, Inc.'s stock has declined approximately -78.2058% over the past 52 weeks. The 50-day moving average sits at 4.43, while the 200-day moving average is 5.55.

Beta (5Y)N/A
52-Week Price Change-78.2058%
50-Day Moving Average4.43
200-Day Moving Average5.55
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Outset Medical, Inc. generated 117.59M in revenue and converted that into -74.85M in net income, yielding earnings per share of -4.17. EBITDA reached -63.38M, while operating income came in at -67.23M.

Revenue117.59M
Gross Profit47.78M
Operating Income-67.23M
Pretax Income-74.03M
Net Income-74.85M
EBITDA-63.38M
EBIT-67.23M
Earnings Per Share (EPS)-4.17

Balance Sheet

Outset Medical, Inc. holds 156.71M in cash and equivalents against 101.61M in total debt, resulting in a net debt position of 66.38M. Total book value stands at -1.19B, with working capital of 199.10M providing operational flexibility.

Cash & Cash Equivalents156.71M
Total Debt101.61M
Net Debt66.38M
Equity (Book Value)-1.19B
Book Value Per Share-66.39
Working Capital199.10M

Cash Flow

Outset Medical, Inc. produced -33.51M in operating cash flow over the past twelve months. After subtracting -740,000.00 in capital expenditures, free cash flow totaled -34.25M - equivalent to -1.91 per share.

Operating Cash Flow-33.51M
Capital Expenditures-740,000.00
Free Cash Flow-34.25M
FCF Per Share-1.91

Margins

Outset Medical, Inc. operates with a gross margin of 40.64, reflecting its pricing power and cost economics. The operating margin of -57.17 and net profit margin of -63.65 provide insight into operational efficiency.

Gross Margin40.64
Operating Margin-57.17
Pretax Margin-62.96
Profit Margin-63.65
EBITDA Margin-53.90

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-0.51
FCF Yield-47.60

Stock Splits

Outset Medical, Inc.'s most recent stock split took place on March 20, 2025 with a 15:1 split ratio.

Last Split Date3/20/2025
Split Ratio15:1

Scores

Outset Medical, Inc. posts an Altman Z-Score of -5.84, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-5.84